HEADER APOPTOSIS 29-OCT-10 2L5B TITLE SOLUTION STRUCTURE OF THE TRANSMEMBRANE DOMAIN OF BCL-2 MEMBER TITLE 2 HARAKIRI IN MICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIVATOR OF APOPTOSIS HARAKIRI; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 61-91; COMPND 5 SYNONYM: BH3-INTERACTING DOMAIN-CONTAINING PROTEIN 3, NEURONAL DEATH COMPND 6 PROTEIN DP5; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: CHEMICALLY SYNTHESIZED KEYWDS APOPTOSIS, BCL-2, BH3-ONLY, HARAKIRI, TRANSMEMBRANE DOMAIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.BARRERA-VILARMAU,P.OBREGON,E.DE ALBA REVDAT 1 14-SEP-11 2L5B 0 JRNL AUTH S.BARRERA-VILARMAU,P.OBREGON,E.DE ALBA JRNL TITL INTRINSIC ORDER AND DISORDER IN THE BCL-2 MEMBER HARAKIRI: JRNL TITL 2 INSIGHTS INTO ITS PROAPOPTOTIC ACTIVITY. JRNL REF PLOS ONE V. 6 21413 2011 JRNL REFN ESSN 1932-6203 JRNL PMID 21731739 JRNL DOI 10.1371/JOURNAL.PONE.0021413 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR_NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2L5B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-NOV-10. REMARK 100 THE RCSB ID CODE IS RCSB101975. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 323 REMARK 210 PH : 3.2 REMARK 210 IONIC STRENGTH : 0.2 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.0-1.5 MM HRK-TM, 200 MM D25 REMARK 210 SDS, 5 MM D15 TCEP, 0.1 MM SODIUM REMARK 210 AZIDE, 35% V/V D3 METHANOL, 95% REMARK 210 H2O/5% D2O; 1.0-1.5 MM HRK-TM, REMARK 210 200 MM D25 SDS, 0.1 MM SODIUM REMARK 210 AZIDE, 5 MM D15 TCEP, 35% V/V D4 REMARK 210 METHANOL, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-13C HSQC; 2D 1H-1H COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRPIPE, PIPP, SPARKY, REMARK 210 TALOS, X-PLOR_NIH REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 2 -157.22 -62.43 REMARK 500 1 ALA A 4 -179.01 -65.23 REMARK 500 1 THR A 7 34.22 -164.41 REMARK 500 1 TYR A 8 18.73 -147.38 REMARK 500 1 ARG A 28 -112.52 -68.53 REMARK 500 1 ASN A 30 16.58 -144.14 REMARK 500 2 THR A 7 19.98 -140.39 REMARK 500 2 TYR A 8 27.57 -156.79 REMARK 500 2 ARG A 28 -113.01 -64.77 REMARK 500 2 ASN A 30 17.06 -144.61 REMARK 500 3 ALA A 4 -75.92 -63.38 REMARK 500 3 PRO A 6 176.55 -59.98 REMARK 500 3 THR A 7 -43.01 -166.27 REMARK 500 3 ARG A 28 -117.32 -69.57 REMARK 500 3 ASN A 30 15.69 -141.99 REMARK 500 4 PRO A 2 -157.08 -62.42 REMARK 500 4 ALA A 4 73.17 53.17 REMARK 500 4 THR A 7 31.79 -164.35 REMARK 500 4 TYR A 8 18.40 -150.18 REMARK 500 4 ARG A 28 -112.41 -61.45 REMARK 500 5 PRO A 2 7.81 -66.87 REMARK 500 5 ALA A 4 -82.56 53.96 REMARK 500 5 ARG A 28 -117.14 -63.33 REMARK 500 6 PRO A 2 0.13 -63.36 REMARK 500 6 THR A 7 -42.07 -165.60 REMARK 500 6 ARG A 28 -116.10 -74.43 REMARK 500 7 PRO A 2 -153.14 -60.38 REMARK 500 7 ALA A 4 28.10 -170.14 REMARK 500 7 LEU A 5 70.10 52.66 REMARK 500 7 THR A 7 26.26 -148.16 REMARK 500 7 TYR A 8 19.49 -140.98 REMARK 500 7 ARG A 28 -119.75 -65.75 REMARK 500 7 ASN A 30 16.81 -140.28 REMARK 500 8 PRO A 2 -158.30 -63.31 REMARK 500 8 ALA A 4 -43.71 -170.42 REMARK 500 8 PRO A 6 -175.45 -62.52 REMARK 500 8 THR A 7 30.51 -159.84 REMARK 500 8 TYR A 8 19.75 -150.27 REMARK 500 8 ARG A 28 -110.88 -69.64 REMARK 500 8 ASN A 30 24.30 -147.42 REMARK 500 9 PRO A 2 -157.07 -62.45 REMARK 500 9 ALA A 4 76.68 -170.55 REMARK 500 9 THR A 7 23.37 -146.51 REMARK 500 9 TYR A 8 26.66 -156.26 REMARK 500 9 ARG A 28 -113.73 -62.89 REMARK 500 9 ASN A 30 12.80 -148.28 REMARK 500 10 ARG A 28 -114.91 -69.03 REMARK 500 11 PRO A 2 -159.47 -58.62 REMARK 500 11 THR A 7 23.61 -147.32 REMARK 500 11 TYR A 8 20.99 -161.98 REMARK 500 REMARK 500 THIS ENTRY HAS 97 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2L5B A 1 31 UNP O00198 HRK_HUMAN 61 91 SEQADV 2L5B NH2 A 32 UNP O00198 AMIDATION SEQRES 1 A 32 ALA PRO GLY ALA LEU PRO THR TYR TRP PRO TRP LEU CYS SEQRES 2 A 32 ALA ALA ALA GLN VAL ALA ALA LEU ALA ALA TRP LEU LEU SEQRES 3 A 32 GLY ARG ARG ASN LEU NH2 HET NH2 A 32 3 HETNAM NH2 AMINO GROUP FORMUL 1 NH2 H2 N HELIX 1 1 TYR A 8 LEU A 26 1 19 LINK C LEU A 31 N NH2 A 32 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1